A recent FDA report cites serious flaws in St. Jude Medical's oversight of design changes made to its Durata line of devices. Earlier this year, STJ had released a heavily redacted version of the FDA's report, but the recent release of the same report by the FDA shows highlights a pattern of inadequate verification and flawed testing procedures that could renew concerns over the safety of the Durata device. Shares -0.3% AH.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Dec 29, 2014)
at Nasdaq.com (Dec 16, 2014)
at Fox Business (Nov 21, 2014)
at Nasdaq.com (Nov 21, 2014)
at CNBC.com (Oct 27, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs